Skip to main content

Table 2 Hyperthermic intraperitoneal chemotherapy related parameters

From: Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients

Parameter

TD (mg), median (range)

95 (85, 120)

Perfusate at the end of HIPEC

 Volume (ml), median (range)

1835 (1050, 2670)

 Concentration of cisplatin (μg/ml), median (range)

11.3 (6.6, 19.4)

 LD (mg), median (range)

20.7 (9.6, 37.8)

AD (mg), median (range)

75.8 (48.3, 92.4)

Utility rate of cisplatina (%), median (range)

79.2 (62.2, 90.4)

  1. AD Actually utilized dose, LD Losing dose, HIPEC Hyperthermic intraperitoneal chemotherapy, TD Total dose;
  2. aUtility rate of cisplatin = actually used dose of cisplatin (mg)/ total dose of cisplatin (mg)